Remeditex Ventures is a private equity general partner firm headquartered in Dallas, TX, United States.
Miragen Therapeutics, a biopharmaceutical company, has raised $40m in funding from Atlas Venture, Boulder Ventures, JAFCO and others.
Navitor Pharmaceuticals, a biopharmaceutical company, secured $33m in Series B funding from Remeditex Ventures, Polaris Partners and others.
miRagen Therapeutics, a biopharmaceutical company developing innovative microRNA-based therapeutics, raised $41m in Series C funding.
Read more news concerning Remeditex Ventures
A sampling of Remeditex Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?